TD Cowen analyst Tyler Van Buren maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) today. The company’s shares closed ...
In a report released today, Tyler Van Buren from TD Cowen maintained a Buy rating on NewAmsterdam Pharma Company (NAMS – Research Report). The company’s shares closed yesterday at $24.66. Don't Miss ...
MDOT is seeking public feedback on a new environmental assessment of the proposed project stretching from Ann Arbor to ...
The College Football Playoff Rankings are almost upon us for Week 13. In them, we’ll see how the committee values two-loss SEC teams and be given a great glimpse at just how many SEC teams can ...
Something clicked within week three of the regular season as the Rockets were on the right side of their BVC opener against Van Buren, winning 41-14 ... but they had depth with players like senior ...
We are in the season of giving but for our next guests giving is always in season. Eric Devendorf, Founder of the ED 23 ...